Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertindole vs Quetiapine for Neurocognition in Schizophrenia
NCT00654706Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertindole in schizophrenia (2 arms), sponsored by Lundbeck. Primary endpoint: MATRICS Consensus Cognitive Battery Overall Composite at 12 weeks. Started Mar 2008; status: completed.
02
Drugs
sertindole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00654706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654706.